Iqvia announces OCE tech deal with Adhera

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/scyther5)
(Image: Getty/scyther5)

Related tags IQVIA Technology

Adhera Therapeutics has selected Iqvia’s Orchestrated Customer Engagement (OCE) technology platform to build its commercial infrastructure.

Adhera Therapeutics is a specialty pharmaceutical company currently focused on commercializing Prestalia (perindopril arginine and amlodipine besylate), which is US Food and Drug Administration (FDA) approved for the treatment of hypertension to lower blood pressure.

Iqvia last week announced that Adhera has selected the OCE platform to build its commercial infrastructure and bring its specialty drugs to patients.

OCE deals

Last month on the company’s third-quarter earnings call​ Iqvia CEO Ari Bousbib said the market for its OCE platform represents a “great”​ opportunity – and the company continues to invest in its technology platform while securing new customers.

In October, Iqvia announced​ that the pharmaceuticals division of Roche would deploy its commercial technology suite across more than 100 markets as part of the multi-year agreement.

The technologies suite includes the OCE Sales/Marketing, Master Data Management (MDM), ePromo, and Organization Manager applications.

The applications are being rolled out to approximately 14,000 users across more than 100 countries.

Earlier this year the company also won deals with Pierre Fabre, Recordati, and PruGen, among other clients in the US and Canada to deploy its commercial operations SaaS software, OCE.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more